Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease
Authors:
Open Access
- 1 October 2010
- journal article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. 3, 127-134
Abstract
Activation of the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) has been shown to be immunoregulatory in autoimmune diseases by inhibiting production of a number of inflammatory mediators. We investigated whether PPAR-γ gene deletion in hematopoietic cells would alter disease pathogenesis in the antiglomerular basement membrane (anti-GBM) mouse model. PPAR-γ+/+ and PPAR-γ-/- mice were immunized with rabbit antimouse GBM antibodies and lipopolysaccharide and evaluated for two weeks. Although both the PPAR-γ+/+ and PPAR-γ-/- mice had IgG deposition in the glomerulus and showed proteinuria two weeks after injection, glomerular and tubulointerstitial disease in PPAR-γ-/- mice were significantly more severe compared with the PPAR-γ+/+ animals. We observed that the PPAR-γ-/- mice had decreased CD4+CD25+ regulatory T cells and an increased CD8+:CD4+ ratio as compared with the PPAR-γ+/+ mice, suggesting that PPAR-γ has a role in the regulation of T cells. Furthermore, plasma interleukin-6 levels were significantly increased in the PPAR-γ-/- mice at two weeks as compared with the PPAR-γ+/+ animals. Taken together, these studies show that the lack of PPAR-γ expression enhances inflammatory renal disease in the anti-GBM antibody-induced glomerulonephritis mouse model and suggests targeting PPAR-γ may have therapeutic efficacy.Keywords
This publication has 42 references indexed in Scilit:
- Immunoregulatory Actions of Epithelial Cell PPAR γ at the Colonic Mucosa of Mice with Experimental Inflammatory Bowel DiseasePLOS ONE, 2010
- Phospholipase A 2 –Modified Low-Density Lipoprotein Activates Macrophage Peroxisome Proliferator–Activated ReceptorsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- The Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Ameliorates Murine Lupus by Induction of AdiponectinThe Journal of Immunology, 2009
- Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/MpJ-Faslpr miceJournal of Lipid Research, 2006
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*Endocrine Reviews, 1999
- The pulmonary-renal syndrome: a poorly understood clinicopathologic conditionLupus, 1999
- Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagenKidney International, 1998
- PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoterFEBS Letters, 1998
- Expression of the Peroxisome Proliferator-Activated Receptor (PPAR) in the Mouse Colonic MucosaBiochemical and Biophysical Research Communications, 1996
- The RXR heterodimers and orphan receptorsCell, 1995